MIRA Pharmaceuticals, Inc. (MIRA)

MIRA Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	2.83	4.6	0.35	2.81	0
Cash & Short-Term Investments	2.83	4.6	0.35	2.81	0
Cash Growth	-38.45%	1211.36%	-87.51%	80379.86%	-
Other Receivables	-	0.01	-	-	-
Receivables	-	0.01	-	-	-
Prepaid Expenses	0.05	0.24	-	-	-
Other Current Assets	-	-	0.14	0.1	-
Total Current Assets	2.89	4.86	0.49	2.91	0
Property, Plant & Equipment	-	0.01	0.36	-	-
Long-Term Accounts Receivable	0.04	0.07	-	-	-
Other Long-Term Assets	-	-	-	0.45	0.02
Total Assets	2.92	4.93	0.86	3.36	0.02
Accounts Payable	0.72	0.54	0.91	0.78	-
Accrued Expenses	-	0.01	0.06	0.02	0
Short-Term Debt	-	-	0.13	0.29	0.09
Current Portion of Leases	-	0.01	0.27	-	-
Total Current Liabilities	0.72	0.56	1.37	1.09	0.09
Long-Term Leases	-	-	0.08	-	-
Total Liabilities	0.72	0.56	1.45	1.09	0.09
Common Stock	0	0	0.01	0.01	0.01
Additional Paid-In Capital	31.34	25.66	8.7	4.5	-
Retained Earnings	-29.14	-21.29	-9.3	-2.24	-0.07
Comprehensive Income & Other	-	-	-	-	-0.01
Shareholders' Equity	2.2	4.37	-0.6	2.26	-0.07
Total Liabilities & Equity	2.92	4.93	0.86	3.36	0.02
Total Debt	-	0.01	0.49	0.29	0.09
Net Cash (Debt)	2.83	4.6	-0.14	2.52	-0.09
Net Cash Growth	-38.38%	-	-	-	-
Net Cash Per Share	0.18	0.25	-0.01	0.20	-
Filing Date Shares Outstanding	16.81	14.78	13.31	12.67	-
Total Common Shares Outstanding	16.56	14.78	13.31	12.67	-
Working Capital	2.16	4.3	-0.88	1.82	-0.09
Book Value Per Share	0.13	0.30	-0.04	0.18	-
Tangible Book Value	2.2	4.37	-0.6	2.26	-0.07
Tangible Book Value Per Share	0.13	0.30	-0.04	0.18	-

Updated Nov 12, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q